CYTOKINE PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND METABOLIC TURNOVER OF BONE DURING PREGNANCY

被引:5
作者
FUKUOKA, H
KIRIYAMA, M
HIGURASHI, M
HONDA, T
SATOH, K
OOISHI, T
KUSHIDA, K
INOUE, T
机构
[1] NIHON UNIV, DEPT OBSTET & GYNECOL, ITABASHI KU, TOKYO 173, JAPAN
[2] HAMAMATSU UNIV SCH MED, DEPT ORTHOPED SURG, HAMAMATSU, SHIZUOKA 48131, JAPAN
来源
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES | 1993年 / 69卷 / 08期
关键词
METABOLIC MARKER OF BONE TURNOVER; DEOXYPYRIDINOLINE; CYTOKINE; INTACT OSTEOCALCIN; INTERLEUKIN; 1; TUMOR NECROSIS FACTOR-ALPHA;
D O I
10.2183/pjab.69.212
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We studied the dynamic turnover of bone by measuring metabolic markers in 6 healthy pregnant women, aged 23-28. Resorption markers, tartrate-resistant acid phosphatase and deoxypyridinoline, increased in the last trimester and after partrition decreased until puerperium day 30. The serum level of intact osteocalcin, a formation marker, exhibited a slight decrease during pregnancy and increased following childbirth. In the last trimester, the peripheral monocyte secreted much amount of interleukin (IL)-1 and tumor necrosis factor (TNF)-alpha, potent stimulants of osteoclast, in parallel with the resorption markers. Estrogen has the bone sparing effect by inhibiting cytokine secretion in the bone microenvironment and peripheral mononuclear cell. Biomarker changes, however, disclosed uncoupling of bone with high resorption and low formation in the last trimester with a higher estrogen level than any other period of life, which might be mediated by a high amount of IL-1 and TNF-alpha through stimulating osteoclast activity.
引用
收藏
页码:212 / 217
页数:6
相关论文
共 14 条
[1]  
BEARDSWORTH LJ, 1990, J BONE MINER RES, V5, P671
[2]  
BROOKS GG, 1990, J REPROD MED, V35, P969
[3]   UNCHANGED TOTAL-BODY CALCIUM IN NORMAL HUMAN PREGNANCY [J].
CHRISTIANSEN, C ;
RODBRO, P ;
HEINILD, B .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1976, 55 (02) :141-143
[4]  
DRINKWATER BI, 1991, BONE MINER, V14, P151
[5]   BONE-MINERAL - EFFECTS OF ORAL-CONTRACEPTIVES, PREGNANCY, AND LACTATION [J].
GOLDSMITH, NF ;
JOHNSTON, JO .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1975, 57 (05) :657-668
[6]   OSTEOPOROSIS ASSOCIATED WITH PREGNANCY AND LACTATION - BONE-BIOPSY AND SKELETAL FEATURES IN 3 PATIENTS [J].
GRUBER, HE ;
GUTTERIDGE, DH ;
BAYLINK, DJ .
METABOLIC BONE DISEASE & RELATED RESEARCH, 1984, 5 (04) :159-165
[7]  
HOSODA K, 1992, CLIN CHEM, V38, P2233
[8]  
LAU KHW, 1985, J BIOL CHEM, V260, P4653
[9]   IS THERE A CAUSAL ROLE FOR IL-1 IN POSTMENOPAUSAL BONE LOSS [J].
PACIFICI, R .
CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (04) :295-299
[10]   OVARIAN-STEROID TREATMENT BLOCKS A POSTMENOPAUSAL INCREASE IN BLOOD MONOCYTE INTERLEUKIN-1 RELEASE [J].
PACIFICI, R ;
RIFAS, L ;
MCCRACKEN, R ;
VERED, I ;
MCMURTRY, C ;
AVIOLI, LV ;
PECK, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) :2398-2402